Robert DillardProstate Cancer | July 21, 2022
Increases in non-healthy behaviors such as drinking and less exercise has been attributed to the COVID-19 pandemic.
Read More
HealthDay NewsRLT | September 20, 2022
The incidence was seen with the use of 18F-fluorocholine PET/CT and 68Ga-PSMA-11 PET/CT.
Kerri FitzgeraldSNMMI 2022 Meeting | November 11, 2022
The study is the first to show that lingering COVID-19 symptoms can be attributed to ongoing lung inflammation.
GU Oncology Now EditorsProstate Cancer | September 19, 2022
This study offers a realist approach to rethinking and operationalizing the WHO 2017 guide to cancer early diagnosis.
Robert DillardProstate Cancer | February 5, 2024
Researchers examined the association between the pandemic and prostate biopsy and cancer diagnosis.
Akhil Abraham Saji, MDJournal | November 30, 2022
An overview of the effects of the COVID-19 pandemic on patient care and its effects on oncology care and medical education.
GU Oncology Now EditorsJournal | November 30, 2022
The COVID-19 pandemic has brought about unprecedented changes in urologic care.
Robert DillardJournal | December 14, 2021
A scientific session from the SNMMI Annual Meeting details how imaging can assess the impact of COVID-19 in cancer patients.
GU Oncology Now EditorsRLT | November 5, 2021
The COVID-19 outbreak impacted patients with prostate cancer by causing a delay in the administration treatment.
Robert DillardAUA 2021 | September 10, 2021
Patients with COVID-19 reported increased genitourinary symptoms.
Robert DillardUrothelial Carcinoma | July 6, 2021
Previous Bacillus Calmette-Guérin therapy impacts COVID risk in bladder cancer.
Ariel JonesASCO 2021 | June 4, 2021
A study evaluated trends in outpatient prostate cancer throughout the COVID-19 pandemic using a community-based registry.
The UromigosThe Uromigos | May 29, 2020
Jeremy Warner summarizes the paper published in Lancet describing the outcome of cancer patients with COVID-19.